Menu
Recruiting NCT06910267

Leveraging Adult Protective Service Interaction to Offer Evidence-Based Treatment for Depression in Elder Neglect/Self Neglect

No phase Interventional Depression in Old Age

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: APS Treatment as Usual, Intervention-Behavioral Activation (BA).
Who it may be relevant to
Registry conditions: Depression in Old Age. Basic parameters: from 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The purpose of this study is to test the feasibility and acceptability of an evidence-based treatment for depression delivered over an ipad, computer, or smartphone can help Adult Protective Services (APS) clients with their activities of daily living to evaluate whether reductions on measures of depression and apathy (a) mediate reduced Elder Neglect/Self Neglect (EN/SN) behaviors; and (b) whether secondary posited mediating mechanisms are also active in impacting depression and apathy

Interventions

  • Behavioral APS Treatment as Usual
    APS agencies conduct in-home investigations of alleged abuse and neglect against disabled and older adults. Investigations result in short-term stop-gap measures, primarily brief case-management centering on referral linkage to community-based services and provision of resource allocation. No direct psychological services or treatments are provided by APS, however referral to other services is also standard.
  • Behavioral Intervention-Behavioral Activation (BA)
    Participants will be will be guided through 8 one-hour sessions via home telehealth by the study community health worker. Each weekly \< 60 minute BA session will include modules focusing on 1) Psychoeducation for depression and techniques for self-management, including pharmacologic and psychosocial treatment options; 2) Introduction of BA and guided problem-solving techniques to enhance self efficacy for managing depression and other chronic illnesses; 3) BA and problem-solving techniques to s

Primary outcome measures

  • Change in depression as assessed by the Patient Depression Questionnaire (PHQ-9) [Time frame: baseline, post-treatment ( 8 weeks after baseline), and 3 months]
  • Change in apathy as assessed by the Apathy Motivations Index (AMI) [Time frame: baseline, post-treatment ( 8 weeks after baseline), and 3 months]
  • Change in Elder Neglect/Self Neglect (EN/SN) as evidenced by study developed goal attainment scale [Time frame: baseline, post-treatment ( 8 weeks after baseline), and 3 months]
Secondary outcome measures (2)
  • Change in social connection as assessed by the Lubben Social Network Scale [Time frame: baseline, post-treatment ( 8 weeks after baseline), and 3 months]
  • Change in social isolation as assessed by Patient-Reported Outcomes Measurement Information System (PROMIS 8) [Time frame: baseline, post-treatment ( 8 weeks after baseline), and 3 months]

Eligibility criteria

Inclusion criteria

  • APS Case in APS Region VI- Must have open case
  • PHQ 9 score- Must have score of nine (9) or more

Exclusion criteria

  • Previous mental health diagnosis of bipolar disorder, psychotic disorders, and moderate to severe dementia
  • Assessment of Consent Proxy- Those who need assessment of consent proxy
  • Suicidal Intent (as indexed by PhQ-9 question 9)- Those scoring 2 or 3
  • Current Alcohol and Drug Dependency- As evidenced by Cut down, Annoyed, Guilty, and Eye-opener (CAGE) score of 3 or more

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

United States · 1 center
  • The University of Texas Health Science Center at Houston — Houston

Identifiers

NCT: NCT06910267 · HSC-MS-24-1021 · 1P30AG086563-01

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗